International Journal of Cancer · 1973 · 103 citations · 20 references
Life SciencesImmunologyOncologyCancer ImmunologyCellular ImmunologyTumor ImmunologyCell-mediated ImmunityCellular Immunity In InfectionCytotoxic T Lymphocyte ResponsesOncogenic VirusesT Cell Responses To TumorsTumor-associated AntigensCellular Immune Response To VirusesSyngeneic Tumor ModelsT-cell Responses To Tumor AntigensTumor ReactivityViral Tumor Antigens
Abstract The nature of the effector cells detected by the chromium release test (CRT) has been studied in BALB/c and C57Bl/6 mice bearing murine sarcoma virus (MSV)‐induced tumors. Anti‐θ‐C3H immune sera completely inhibited the cytotoxic activity of lymphoid cells in the presence of complement; anti‐immunoglobulin sera failed to decrease this activity. No activation of normal non‐sensitized lymphoid cells in the presence of heat‐decomplemented sera from mice bearing MSV‐induced sarcomas could be obtained. Identical results have been found in allogeneic systems with major H‐2 histocompatibility antigens. It can be concluded that a thymus‐processed lymphoid cell sub‐population sharing the θ antigen is exclusively or very predominantly responsible for the immune cytolysis both in syngeneic tumor systems and in allogeneic transplantation systems.
20
Plaque Formation in Agar by Single Antibody-Producing Cells
N. K. Jerne, Albert A. Nordin · Science · 1963 · 2.4K citations
A RECEPTOR FOR ANTIBODY ON B LYMPHOCYTES
Antony Basten, J. F. A. P. Miller, J. Sprent et al. · The Journal of Experimental Medicine · 1972 · 462 citations · Full text
Theta Isoantigen as a Marker of Thymus-derived Lymphocytes in Mice
Martin Raff · Nature · 1969 · 446 citations